| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/24/2013 | US8541385 Chemically modified oligonucleotides for use in modulation micro RNA and uses thereof |
| 09/24/2013 | US8541384 Gene expression inhibition using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR; diabetic retinopathy, age related macular degeneration and many types of cancer |
| 09/24/2013 | US8541376 Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 09/24/2013 | US8541237 Method for diagnosing disease using adenovirus harboring trans-splicing ribozyme by molecular imaging |
| 09/24/2013 | US8541231 Elimination of N-glycolylneuraminic acid from animal products for human use |
| 09/24/2013 | US8541230 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 09/24/2013 | US8541004 Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 09/24/2013 | US8540979 Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein |
| 09/24/2013 | CA2595517C Drug carrier and drug carrier kit for inhibiting fibrosis |
| 09/24/2013 | CA2522359C Pathotropic retroviral vector used to deliver diagnostic or therapeutic compositions |
| 09/24/2013 | CA2486583C Marker molecules associated with lung tumors |
| 09/24/2013 | CA2480656C Bioadhesive directed somatic cell therapy |
| 09/24/2013 | CA2476410C Methods to increase or decrease bone density |
| 09/24/2013 | CA2434760C Differentiated cells suitable for human therapy |
| 09/24/2013 | CA2425669C Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/24/2013 | CA2405557C Albumin fusion proteins |
| 09/19/2013 | WO2013138790A1 Combination therapies including inhibitors of the extracellular domain of e-cadherin |
| 09/19/2013 | WO2013138783A1 A NOVEL RNAi MOLECULE DELIVERY PLATFORM BASED ON SINGLE-siRNA AND shRNA NANOCAPSULES |
| 09/19/2013 | WO2013138463A1 Neurofibromatoses therapeutic agents and screening for same |
| 09/19/2013 | WO2013138456A1 Lim kinasemodulating agents for neurofibromatoses therapy and methods for screening for same |
| 09/19/2013 | WO2013138353A2 Compositions and methods for modulation of atxn3 expression |
| 09/19/2013 | WO2013138280A1 IMPROVED ENGRAFTMENT POTENTIAL OF EMBRYONIC STEM CELLS AND PLURIPOTENT STEM CELLS USING MICRO RNAs |
| 09/19/2013 | WO2013136078A1 Therapeutic use of p75ntr neurotrophin binding protein |
| 09/19/2013 | WO2013118109A8 Methods and apparatuses harvesting, modifying and reimplantation of dermal micro -organs |
| 09/19/2013 | WO2013113030A3 Fads regulation |
| 09/19/2013 | US20130245106 Method of producing a protein of interest |
| 09/19/2013 | US20130245105 Dlin-kc2-dma lipid nanoparticle delivery of modified polynucleotides |
| 09/19/2013 | US20130245104 Method for producing a protein of interest in a primate |
| 09/19/2013 | US20130245090 Identification of novel genes coding for small temporal rnas |
| 09/19/2013 | US20130243796 Genetic products differentially expressed in tumors and use thereof |
| 09/19/2013 | US20130243755 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/19/2013 | US20130243730 Rna interference for the treatment of heart failure |
| 09/19/2013 | US20130243697 Novel Chimeric Proteins and Methods for Using The Same |
| 09/18/2013 | EP2638918A1 Method and device for treating blood cholesterol disorders |
| 09/18/2013 | EP2638917A1 Method of fixing and expressing physiologically active substance |
| 09/18/2013 | EP2638912A1 Compositions containing antisense oligonucleotide to micro rna |
| 09/18/2013 | EP2637702A1 Methods, compositions, cells, and kits for treating ischemic injury |
| 09/18/2013 | EP2637683A2 Methods for organ regeneration |
| 09/18/2013 | CN1694959B Non-sequence complementary antiviral oligonucleotides |
| 09/18/2013 | CN103314109A SiRNA for inhibition of Hif1a expression and anticancer composition containing same |
| 09/18/2013 | CN103314107A Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence |
| 09/18/2013 | CN103314106A A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy |
| 09/18/2013 | CN103313730A Compositions of a peptide-based system for cell-specific targeting |
| 09/18/2013 | CN103305596A Application and related pharmaceuticals of human ubiquitin-protein ligase 138 (RNF138) gene |
| 09/18/2013 | CN103305549A Genetic vector system of nanoparticle with multiple oxidation-reduction stimulus response as well as preparation method and application of genetic vector system |
| 09/18/2013 | CN103305548A Method for expressing exogenous and endogenous genes by mouse intestinal DC cell mediated by oral gene engineering fermenting yeast and application |
| 09/18/2013 | CN103305535A Gene sequence of pig histone deacetylase 6 and application thereof |
| 09/18/2013 | CN103305534A Reverse genetics operating system of mink enteritis virus and application thereof |
| 09/18/2013 | CN103305521A Sequence of aptamer of gastric cancer cell, and application thereof |
| 09/18/2013 | CN103305519A Aptamer sequence of hepatitis B virus (HBV) core antigen, and applications thereof |
| 09/18/2013 | CN103305518A shRNA of human CD14 gene and application thereof |
| 09/18/2013 | CN103305515A Family with sequence similarity 84, member B (FAM84B) antisense nucleotide and application thereof |
| 09/18/2013 | CN103305475A Establishment method and application of enterovirus (EV) 71-gene modification system |
| 09/18/2013 | CN103304644A Haemophilus parasuis (Hps) immune protective antigen OppA2 |
| 09/18/2013 | CN103304643A Haemophilus parasuis (Hps) immune protective antigen CdtA |
| 09/18/2013 | CN103304445A Cation polyglycerol ester lipid and synthetic method and application thereof |
| 09/18/2013 | CN103301477A Application of escherichia coli succinodehydrogenase iron-sulfur protein SdhB |
| 09/18/2013 | CN103301476A Porcine epizootic diarrhea gene recombinant vaccine as well as constructed primer and construction method thereof |
| 09/18/2013 | CN103301475A Natural antisense and non-coding rna transcripts as drug targets |
| 09/18/2013 | CN103301474A Usage and related drugs of human RNF40 gene |
| 09/18/2013 | CN102676518B Novel anti-tumor amiRNA (artificial micro Ribonucleic Acid) sequence and application thereof |
| 09/18/2013 | CN102268455B CEA (chorioembryonic antigen) recombinant adeno-associated viral vector, constructing method thereof and application thereof |
| 09/18/2013 | CN102145163B Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity |
| 09/18/2013 | CN102140470B Human miR-1236 antisense ribonucleic acid and application thereof |
| 09/18/2013 | CN102133430B Inductive agent for regeneration of periodontium tissue of temperature sensitivity and preparation method thereof |
| 09/18/2013 | CN101966332B Application of gap junction protein and coding gene thereof in preparing medicament for reversing malignant phenotype of cancer stem cell |
| 09/18/2013 | CN101962642B Interference RNA for targeting CCP22 gene, medicament composition containing interference RNA and application thereof |
| 09/18/2013 | CN101671679B Resistance-relevant gene and applications of radiation-resistant cocci |
| 09/18/2013 | CN101573449B A DNA vaccine for curing chronic hepatitis b and a method of preparing same |
| 09/17/2013 | US8536311 Inhibitor protein of the wnt signal pathway |
| 09/17/2013 | US8536304 Tumour-associated peptides that bind to MHC molecules |
| 09/17/2013 | US8536149 TRPM-2 antisense therapy |
| 09/17/2013 | US8536148 Disabling autophagy as a treatment for lysosomal storage diseases |
| 09/17/2013 | US8536145 Introducing genetic material topically or by lavage into mucosal tissue cells of an individual, including rectal, vaginal, urethral, sublingual and buccal; used to deliver genetic material that encodes protein targets for immunization against pathogen infection, hyperproliferative or autoimmune diseases |
| 09/17/2013 | US8535899 Assay for identifying a modulator of HIF hydroxylase |
| 09/17/2013 | US8535690 Tumor specific animal proteins |
| 09/17/2013 | US8535685 H3 equine influenza A virus |
| 09/17/2013 | US8535682 Recombinant vaccine against West Nile Virus |
| 09/17/2013 | US8535658 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 09/17/2013 | CA2574088C Oligonucleotides comprising a modified or non-natural nucleobase |
| 09/17/2013 | CA2562685C Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety |
| 09/17/2013 | CA2515890C Novel insertion sites in pox vectors |
| 09/17/2013 | CA2451738C Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine |
| 09/17/2013 | CA2445381C Phosphorous antimicrobial compounds and methods for their use |
| 09/17/2013 | CA2423093C Improved system for regulation of transgene expression |
| 09/17/2013 | CA2348382C Chimeric parvovirus vectors and methods of making and administering the same |
| 09/17/2013 | CA2285701C .beta.-catenin, tcf-4, and apc interact to prevent cancer |
| 09/12/2013 | WO2013134777A1 Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders |
| 09/12/2013 | WO2013134766A2 Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disorders |
| 09/12/2013 | WO2013134626A1 Prevention and treatment of respiratory infection with peroxisome proliferator activator receptor delta agonist |
| 09/12/2013 | WO2013134558A1 Cancer treatment targeting non-coding rna overexpression |
| 09/12/2013 | WO2013134416A1 Use of the chromosome 19 microrna cluster (c19mc) for treating microbial disease and promoting authophagy |
| 09/12/2013 | WO2013134293A1 Vaccine formulation |
| 09/12/2013 | WO2013134022A1 Regeneration of inner ear cells |
| 09/12/2013 | WO2013133450A1 Pharmaceutical composition for treating cancer |
| 09/12/2013 | WO2013133393A1 Single-stranded nucleic acid molecule for inhibiting vegf gene expression |
| 09/12/2013 | WO2013133221A1 micro-RNA INHIBITOR |
| 09/12/2013 | WO2013131644A1 A novel drug delivery system based on jcv-vlp |
| 09/12/2013 | WO2013131143A1 Micrornas and uses thereof |
| 09/12/2013 | WO2013106766A3 THERAPEUTIC INDICATIONS OF miR-1291 |